Masaya Tanno Selected Research

SB 203580

9/2009	MAPKAPK-2 modulates p38-MAPK localization and small heat shock protein phosphorylation but does not mediate the injury associated with p38-MAPK activation during myocardial ischemia.
2/2009	Roles of Cx43-associated protein kinases in suppression of gap junction-mediated chemical coupling by ischemic preconditioning.
10/2005	Antimycin A induced cardioprotection is dependent on pre-ischemic p38-MAPK activation but independent of MKK3.
12/2003	Tumor necrosis factor-induced protection of the murine heart is independent of p38-MAPK activation.
8/2003	Diverse mechanisms of myocardial p38 mitogen-activated protein kinase activation: evidence for MKK-independent activation by a TAB1-associated mechanism contributing to injury during myocardial ischemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masaya Tanno Research Topics

Disease

27	Infarction (Infarctions) 01/2018 - 07/2002
21	Ischemia 01/2018 - 07/2002
9	Type 2 Diabetes Mellitus (MODY) 01/2021 - 12/2009
8	Necrosis 02/2021 - 06/2010
7	Myocardial Infarction 01/2020 - 04/2006
5	Reperfusion Injury 02/2021 - 11/2007
5	Heart Failure 01/2018 - 03/2010
5	Fibrosis (Cirrhosis) 02/2016 - 03/2010
4	Myocardial Ischemia (Ischemic Heart Diseases) 01/2018 - 08/2003
3	Cardiomyopathies (Cardiomyopathy) 02/2016 - 02/2013
2	Hyperglycemia 06/2021 - 01/2020
2	Left Ventricular Dysfunction 01/2021 - 01/2012
2	Acute Kidney Injury (Acute Renal Failure) 01/2020 - 12/2017
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 01/2017
2	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 02/2016 - 03/2010
2	Muscular Dystrophies (Muscular Dystrophy) 08/2015 - 09/2011
2	Cardiomegaly (Heart Hypertrophy) 08/2015 - 02/2013
2	Hypertrophy 02/2013 - 01/2011
2	Ventricular Remodeling 04/2006 - 05/2003
1	Hypoglycemia (Reactive Hypoglycemia) 06/2021
1	Infections 06/2021
1	Oliguria 02/2021
1	Ventricular Dysfunction 01/2021
1	Insulin Resistance 01/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Coronary Stenosis (Coronary Artery Stenosis) 01/2021
1	Neoplasms (Cancer) 12/2019
1	Diabetes Mellitus 07/2019
1	Cardio-Renal Syndrome 07/2019
1	Chronic Renal Insufficiency 01/2016
1	Coronary Occlusion 01/2016

Drug/Important Bio-Agent (IBA)

8	Erythropoietin FDA Link 12/2012 - 04/2006
6	Proteins (Proteins, Gene)FDA Link 01/2019 - 09/2011
6	salicylhydroxamic acid (SHAM)IBA 01/2018 - 05/2003
5	Adenosine Triphosphate (ATP)IBA 01/2018 - 07/2002
5	Mitochondrial Permeability Transition PoreIBA 01/2018 - 11/2007
5	Sirtuin 1IBA 08/2015 - 03/2010
5	Glycogen Synthase Kinase 3 betaIBA 10/2010 - 08/2006
5	SB 203580IBA 09/2009 - 08/2003
4	ResveratrolIBA 08/2015 - 03/2010
4	Leucine-2-Alanine Enkephalin (Enkephalin, Leucine 2 Alanine)IBA 06/2012 - 09/2006
4	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 05/2012 - 12/2009
4	Protein Kinases (Protein Kinase)IBA 12/2010 - 10/2006
4	Protein Kinase C-epsilonIBA 02/2009 - 07/2002
3	Glucose (Dextrose)FDA LinkGeneric 06/2021 - 07/2019
3	empagliflozinIBA 01/2020 - 01/2018
3	Sodium-Glucose Transporter 2 InhibitorsIBA 07/2019 - 01/2018
3	Dihydrotachysterol (AT 10)IBA 01/2018 - 12/2003
3	Antimycin AIBA 06/2012 - 10/2005
3	Phosphotransferases (Kinase)IBA 12/2010 - 01/2004
3	delta Opioid Receptors (delta Opioid Receptor)IBA 01/2010 - 09/2006
3	lucifer yellowIBA 02/2009 - 01/2004
3	Connexin 43 (Connexin43)IBA 02/2009 - 01/2004
3	Protein Kinase CIBA 02/2009 - 10/2002
2	Urea (Carbamide)FDA LinkGeneric 06/2021 - 02/2021
2	NitrogenIBA 06/2021 - 02/2021
2	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 01/2021 - 02/2013
2	AntioxidantsIBA 01/2019 - 09/2011
2	DystrophinIBA 08/2015 - 02/2013
2	Sarcoglycans (beta Sarcoglycan)IBA 08/2015 - 09/2011
2	NAD (NADH)IBA 02/2013 - 09/2011
2	HexokinaseIBA 05/2012 - 06/2010
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2011 - 10/2006
2	Mitochondrial Proteins (Mitochondrial Protein)IBA 01/2011 - 10/2010
2	SB 216763IBA 11/2010 - 08/2006
2	Diazoxide (Hyperstat)FDA Link 11/2010 - 07/2002
2	Cyclophilins (Cyclophilin)IBA 11/2010 - 06/2010
2	ATP Translocases Mitochondrial ADPIBA 11/2010 - 06/2010
2	EnkephalinsIBA 01/2010 - 09/2007
2	Acetates (Acetic Acid Esters)FDA Link 01/2010 - 09/2007
2	Valsartan (Vals)FDA Link 01/2010 - 05/2003
2	MAP-kinase-activated kinase 2IBA 09/2009 - 06/2003
2	Heptanol (1 Heptanol)IBA 09/2007 - 01/2004
2	BuffersIBA 10/2006 - 01/2004
2	p38 Mitogen-Activated Protein KinasesIBA 01/2004 - 08/2003
1	Insulin (Novolin)FDA Link 06/2021
1	PotassiumIBA 06/2021
1	Hemoglobins (Hemoglobin)IBA 06/2021
1	CreatinineIBA 02/2021
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 02/2021
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2021
1	Adenine NucleotidesIBA 01/2021
1	LipidsIBA 01/2021
1	AMP Deaminase (Myoadenylate Deaminase)IBA 01/2021
1	benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketoneIBA 12/2019
1	SodiumIBA 07/2019
1	CanagliflozinIBA 07/2019
1	Toll-Like Receptors (Toll-Like Receptor)IBA 12/2017
1	Blood Glucose (Blood Sugar)IBA 01/2017
1	Ku 0063794IBA 01/2017
1	Angiotensin Receptor AntagonistsIBA 02/2016
1	Mechanistic Target of Rapamycin Complex 1IBA 02/2016
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 02/2016
1	Erythropoietin Receptors (Erythropoietin Receptor)IBA 01/2016
1	malic acid (malate)IBA 01/2016
1	Aspartic Acid (Aspartate)FDA Link 01/2016

Therapy/Procedure

4	Ligation 01/2018 - 05/2003
2	Oral Administration 02/2013 - 03/2010
2	Therapeutics 07/2012 - 03/2010
1	Nephrectomy 01/2017